Lexaria Bioscience Corp. (LEXX) vs Traws Pharma, Inc. (TRAW)
Lexaria Bioscience Corp. and Traws Pharma, Inc. are both Biotechnology companies. Lexaria Bioscience Corp. and Traws Pharma, Inc. are of similar size ($7.3M and $7.1M). Traws Pharma, Inc. grew revenue faster over the last twelve months: 1,159.3% against 9.08%. Across the 13 metrics below, Traws Pharma, Inc. leads on 7 and Lexaria Bioscience Corp. on 6.
Valuation
Profitability
| Metric | LEXX | TRAW | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (162.60%) | (319.42%) | (57.72%) |
| Return on assets | (134.20%) | (117.35%) | (49.22%) |
| Return on invested capital | (662.56%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack